Dexxon Holdings Ltd., 10% Owner at Urovant Sciences Ltd. (UROV), bought 17,571 shares at $7.55 ($133K) on 2019-05-29, disclosed to the SEC on 2019-05-29.
Open-market purchase of $133k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.68 | 3,807 | $29K | 22.0% |
| 2 | $7.55 | 6,882 | $52K | 39.0% |
| 3 | $7.55 | 6,882 | $52K | 39.0% |
| Total | $7.58 avg | 17,571 | $133K | 100% |
| Filing → |
| UROV | BUY | 2019-05-20 | $82K | — | Filing → |
| AXON | BUY | 2019-03-19 | $20.0M | — | Filing → |
| AXON | BUY | 2018-12-20 | $10.0M | — | Filing → |